Toward the design of cannabinoid CB1 receptor inverse agonists and neutral antagonists

@article{Reggio2009TowardTD,
  title={Toward the design of cannabinoid CB1 receptor inverse agonists and neutral antagonists},
  author={P. Reggio},
  journal={Drug Development Research},
  year={2009},
  volume={70}
}
  • P. Reggio
  • Published 2009
  • Biology
  • Drug Development Research
The cannabinoid CB1 receptor belongs to Class A of the G‐protein‐coupled receptor (GPCR) family. The high constitutive activity of CB1 facilitates inverse agonism at this receptor, and CB1 inverse agonists/antagonists have recently been considered for the treatment of obesity and metabolic syndrome. GPCRs are assumed to have a common topology and to share a common molecular activation mechanism involving their intracellular domains. However, each individual receptor will also have a molecular… Expand
8 Citations
Ligand-specific homology modeling of human cannabinoid (CB1) receptor.
  • Rizi Ai, C. Chang
  • Chemistry, Medicine
  • Journal of molecular graphics & modelling
  • 2012
  • 15
  • Highly Influenced
Metabolic Profiling of CB1 Neutral Antagonists.
  • 7
Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment.

References

SHOWING 1-10 OF 100 REFERENCES
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.
  • 95
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.
  • 414
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
  • 196
  • PDF
LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.
  • 220
  • PDF
...
1
2
3
4
5
...